Results

Total Results: 1,161 records

Showing results for "patient safety".

141. C- Evidence-based Practice Center Technical Brief Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
     August 05, 2010 - Evidence-based Practice Center Technical Brief Protocol Project Title: Technical Brief - Use and Safety … It requires that the patient be placed in a tube lying flat, either prone or supine. … What are the potential safety issues and harms of positional MRI technologies? … i Types of patients/patient selection criteria: inclusion and exclusion criteria, characteristics of … enrolled patients (demographics, disease spectrum).

142. Ace-Inhibitor-Arb-Update-Surveillance-160328 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
     May 29, 2025 - $Comparative$efficacy$and$safety$of$aliskiren$and$ irbesartan$in$patients$with$hypertension$and$metabolic … $Antihypertensive$efficacy$and$ safety$of$olmesartan$medoxomil$and$ramipril$in$elderly$patients$with … $ rather$than$hypertensive$ patients),$it$highlights$the$safety$ concerns$associated$with$ combining … $Antihypertensive$efficacy$and$safety$of$olmesartan$medoxomil$and$ ramipril$in$elderly$patients$with … $Comparative$efficacy$and$safety$of$aliskiren$and$irbesartan$in$patients$with$ hypertension$and$metabolic

143. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
     June 01, 2022 - Tolerability and safety of lasmiditan treatment in elderly patients with migraine: post hoc analyses … Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine. … Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine. … Cardiovascular safety of erenumab in patients with migraine with or without a history of aura. … Cardiovascular safety of erenumab in patients with migraine and aura.

144. Migraine-Adults-Executive-130408 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
     April 01, 2013 - Which patient characteristics predict the effectiveness and safety of pharmacologic treatments for … KQ 3: Which patient characteristics predict the effectiveness and safety of pharmacologic treatments … Which patient characteristics predict the effectiveness and safety of pharmacological treatments for … on long-term drug benefits and safety. … Influence of Patient Characteristics on the Effectiveness and Safety of Pharmacological Treatments

145. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - For adult patients with essential hypertension, how do ACEIs, ARBs, and DRIs differ in safety, adverse … Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic … Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild … Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension … Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension

146. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
     November 01, 2016 - acceptance is likely to be high because of the ease of administration and good 4 safety profile … A clinical study to evaluate the safety and efficacy of elagolix in subjects with moderate to severe … Study to evaluate the long-term safety and efficacy of elagolix in subjects with moderate to severe … A global phase 3 study to evaluate the safety and efficacy of elagolix in subjects with moderate … Global study to evaluate the long-term safety and efficacy of elagolix in subjects with moderate

147. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
     November 01, 2016 - acceptance is likely to be high because of the ease of administration and good safety profile, most … Study to evaluate the long-term safety and efficacy of elagolix in subjects with moderate to severe … A global phase 3 study to evaluate the safety and efficacy of elagolix in subjects with moderate … Global study to evaluate the long-term safety and efficacy of elagolix in subjects with moderate … A clinical study to evaluate the safety and efficacy of elagolix in subjects with moderate to severe

148. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
     January 01, 2006 - In addition, efficacy and safety may vary for individual drugs within a class. … and no evidence on CV safety … • Almost no data are available on CV safety. … • Compared to placebo, one additional patient achieved pain relief for every eight that used topical … Comparative Effectiveness and Safety of Analgesics for Osteoarthritis.

149. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - , nonwhite patients, and patients with more severe pain and with comorbidities. … The efficacy and safety profile of capsaicin 8% patch versus 5% lidocaine patch in patients with diabetic … The efficacy and safety profile of capsaicin 8% patch versus 5% lidocaine patch in patients with diabetic … Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised … Clinical efficacy and safety profile of topical etofenamate in the treatment of patients with musculoskeletal

150. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - safety evaluation. … , thus disrupting the current health care model for this patient population. … data and postmarket safety evaluation—set forth by FDA. … data and postmarket safety evaluation—set forth by FDA. … would view lorcaserin if it demonstrates safety and efficacy in a majority of patients.

151. breast-cancer-imaging-protocol-131217 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
     December 17, 2013 - • What are the advantages (e.g., sensitivity and specificity) and disadvantages (e.g., safety issues … patients with metastatic breast cancer. … Input from Key Informants will also be sought to determine safety issues that may be associated with … ; (b) health insurance policies; (c) patient preferences. … Patient Advocates [n=3] 1.

152. Migraine-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
     June 01, 2013 - , patient education, drug surveillance, or interactive drug monitoring) improve safety of the treatments … We excluded studies of treatments aimed at acute migraine attacks, studies that involved patients with … We excluded studies that included some pediatric patients with migraine but did not separately report … care, patient education, drug surveillance, or interactive drug monitoring) improve safety of the … however, trials available for review did not report the presence of comorbid illnesses in enrolled patients

153. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - How do harms vary depending on: (1) the specific type or cause of pain, (2) patient demographics, (3 … The efficacy and safety profile of capsaicin 8% patch versus 5% lidocaine patch in patients with diabetic … The efficacy and safety profile of capsaicin 8% patch versus 5% lidocaine patch in patients with diabetic … Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised … Clinical efficacy and safety profile of topical etofenamate in the treatment of patients with musculoskeletal

154. Management of Suicidal Thoughts and Behaviors in Youth: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-exe-sum.pdf
     April 01, 2025 - The median age of the patients was 15.49 years; 75.12 percent were female. 54 percent of the patients … For example, acute safety planning interventions, which were designed to create a safety plan to manage … Journal of Patient Experience. 2022 2022/01/01;9:23743735221079138. doi: 10.1177/23743735221079138. … srsltid=AfmBOopqJlO__q3A9-pmNNMG02Jd1zS5ezAdqeA20n3_JilJrc9lI8ZI https://www.aap.org/en/patient-care/ … srsltid=AfmBOopqJlO__q3A9-pmNNMG02Jd1zS5ezAdqeA20n3_JilJrc9lI8ZI https://www.aap.org/en/patient-care/

155. AHRQ's Evidence-based Practice Center Division Annual Report 2022: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2022.pdf
     January 01, 2022 - Patient Safety Practices To Address Harms Resulting From Patient-Clinician Real-Time Clinical Encounters … Patient Safety Practices To Address Harms Resulting From Patient-Clinician Real-Time Clinical Encounters … /protocol https://effectivehealthcare.ahrq.gov/products/patient-safety-telehealth/protocol https://effectivehealthcare.ahrq.gov … /products/organization-cancer-care/protocol https://effectivehealthcare.ahrq.gov/products/patient-safety-telehealth … Agency for Healthcare Research and Quality (AHRQ) – Center for Quality Improvement and Patient Safety

156. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - of administration would be unlikely to deter liraglutide use if it demonstrates safety and efficacy … Duo positively if it demonstrates safety and efficacy in clinical trials. … , thus disrupting the current health care model for this patient population. … data and postmarket safety evaluation—set forth by FDA. … if it demonstrates both short- and long-term safety and efficacy in a majority of patients.

157. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
     August 01, 2022 - Tolerability and safety of lasmiditan treatment in elderly patients with migraine: post hoc analyses … Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis … Cardiovascular safety of erenumab in patients with migraine with or without a history of aura. … Cardiovascular safety of erenumab in patients with migraine and aura. … Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine.

158. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - o What are the proportions of patients with remission of symptoms (IRLS score = 0), patient-reported … o What are the proportions of patients with remission of symptoms (IRLS score = 0), patient reported … o What are the proportions of patients with remission of symptoms (IRLS score = 0), patient reported … “Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.” … “Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a

159. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
     April 01, 2022 - Patient outcomes following opioid dose reduction among patients with chronic opioid therapy. … Patient outcomes following opioid dose reduction among patients with chronic opioid therapy. … Predicting opioid therapy safety in pancreatic cancer patients. … Patient reported outcomes and neuropsychological testing in patients with chronic non-cancer pain in … Efficacy and safety of morphine hydrochloride in cancer patients with chronic pain.

160. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - In addition to having an increased number of medication choices, patients with type 2 diabetes often … organized these deficiencies and recommendations using the PICOTS format for specifying research questions: patient … Populations Studies often employed narrow inclusion criteria, enrolling patients at lowest risk for … complications, and they commonly used run-in periods to avoid enrolling patients with adverse effects … We identified the following research gaps related to target patient populations: 1.